Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

50.12
Delayed Data
As of 3:59pm ET
 +0.32 / +0.64%
Today’s Change
27.14
Today|||52-Week Range
80.71
-36.86%
Year-to-Date
No recent news for Alkermes Plc.

Today’s Trading

Previous close49.80
Today’s open49.87
Day’s range49.28 - 50.31
Volume653,038
Average volume (3 months)1,175,031
Market cap$7.5B
Dividend yield--
Data as of 3:59pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)-623.81%
Earnings growth (this year)+19.54%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+1.54%
P/E ratioNM
Price/Sales18.85
Price/Book5.71

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...+0.03+0.13%
MNKMallinckrodt Plc+0.32+0.48%
IDXXIDEXX Laboratories I...-1.37-1.45%
JAZZJazz Pharmaceuticals...-0.62-0.44%
Data as of 4:02pm ET, 07/25/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$628.3M
Annual profit (last year)-$227.2M
Net profit margin-36.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers

Search for Jobs